Vyvanse lisdexamfetamine dimesylate regulatory update

FDA approved an sNDA from Shire for Vyvanse lisdexamfetamine dimesylate to treat moderate to severe binge eating disorder in adults. The prodrug of amphetamine is approved to treat ADHD in the U.S., C...